期刊文献+

土槿皮乙酸通过PI3K/Akt信号通路诱导人肾癌细胞A498凋亡 被引量:2

Pseudolaric Acid B Induced the Apoptosis of Human Renal Cell Carcinoma A498 via PI3K/Akt Signaling Pathway
下载PDF
导出
摘要 目的:研究土槿皮乙酸对人肾癌细胞A498凋亡的影响,并探讨其内在的分子机制,为肾癌治疗寻找有效的新靶点和新策略。方法:人肾癌细胞A498经10、15μmol/L土槿皮乙酸处理48 h后,用流式细胞仪检测细胞凋亡,同时通过Western印迹和实时荧光定量PCR检测凋亡相关蛋白和m RNA的表达;加入PI3K/Akt通路抑制剂LY294002或15μmol/L土槿皮乙酸处理A498细胞48 h后,Western印迹检测相关蛋白的表达。结果:经不同浓度土槿皮乙酸作用A498细胞48 h后,与未加土槿皮乙酸组细胞相比,细胞凋亡率显著上升,且呈剂量依赖性,比较差异有统计学意义(P<0.05);同时,Blc-2表达减少,Bax、caspase-9、caspase-3表达增多。Blc-2蛋白的表达量随LY294002或土槿皮乙酸的逐步加入而减少,而Bax、caspase-9、caspase-3的表达呈增加趋势;PI3K和Akt蛋白的表达量与是否加入LY294002或土槿皮乙酸无关,p-PI3K和Aktp-Ser473蛋白的表达量随LY294002或土槿皮乙酸的逐步加入而减少。结论:土槿皮乙酸可抑制A498细胞凋亡,其作用机制可能与PI3K/Akt通路相关。 Objective: To investigate the effect and molecular mechanism of pseudolaric acid B(PAB) on theapoptosis of human renal cell carcinoma A498 and to find a new treatment target for renal cell carcinoma. Methods: A498 cells were incubated with the indicated concentrations of PAB for 48 h and then cell apoptosis was de-termined by flow cytometry. Meanwhile Western blot and real-time quantitative PCR were applied to detect the ex-pression level of related protein and m RNA, respectively. Western blot was performed to determine the expressionof protein after adding PI3K/Akt signaling pathway inhibitor LY294002 and 15 μmol/L PAB. Results: The PAB-in-duced A498 cell apoptosis was significantly increased than that of the control cells. Furthermore, the expression ofBlc-2 was obviously decreased and the levels of Bax, caspase-9, caspase-3 were significantly increased in PAB-treated A498 cells. When A498 cells were traeted with LY294002 or 15 μmol/L PAB, the protein level of Blc-2was decreased and Bax, caspase-9, caspase-3 were significantly increased. Meanwhile, p-PI3 K, Aktp-Ser473 were dra-matically downregulated without PI3 K and Akt. Conclusion: PAB inhibits the apoptosis of human renal cell carci-noma A498 and its mechanism may be related to PI3K/Akt pathway.
出处 《生物技术通讯》 CAS 2016年第4期512-515,共4页 Letters in Biotechnology
基金 辽宁省教育厅优秀人才二层次(LJQ2015112 2015-2018)
关键词 土槿皮乙酸 A498细胞 细胞凋亡 PI3K/Akt信号 pseudolaric acid B A498 cells cell apoptosis PI3K/Akt signaling pathway
  • 相关文献

参考文献12

  • 1Zhang Y, Li Y, Ca; Y, et al. Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center(MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma[J]. Cell Oncol, 2015,39(1):1-7.
  • 2Shichiri M, Hirata Y. Antiangiogenesis signals by endostatin [J]. FASEB J, 2001,15(6):1044-1053.
  • 3Zhang H L, Qin X J, Wang H K, et al. Clinicopathological and prognostic factors for long-term survival in Chinese pa- tients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective study[J]. Oncotarget, 2015,6(34):36870-36883.
  • 4Wang J H, Kan L, Shu L H, et al. Pseudolaric acid B induc- es apoptosis in U937 human leukemia cells via caspase-9me- diated activation of the mitochondrial death pathway[J]. Mol Med Rep, 2013,8(3):787-793.
  • 5Zhao D, Lin F, Wu X, et al. Pseudolaric acid B induces apoptosis via proteasome-mediated Bcl-2 degradation in hor- mone-refractory prostate cancer DU145 cells[J]. Toxicol In Vi- tro, 2012,26(4):595-602.
  • 6Xin M, Deng X. Nicotine inactivation of the proapoptotic func- tion of Bax through phosphorylation[J]. J Biol Chem, 2005,280 (11):10781-10789.
  • 7Coffey J C, Wang J H, Smith M J, et al. Phosphoinositide 3- kinase accelerates postoperative tumor growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis. Novel role for an old enemy[J]. J Biol Chem, 2005, 280(22):20968 -20977.
  • 8Seo B R, Min K J, Cho I J, et al. Curcumin significantly en- hances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-in- duced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhi- bition of Mcl-1 protein stability[J]. PLoS One, 2014,9(4): e95588.
  • 9Li H, Jin X, Zhang Z, et al. Inhibition of autophagy enhanc- es apoptosis induced by the PI3K/Akt/mTor inhibitor NVP- BEZ235 in renal cell carcinoma cells[J]. Cell Bioehem Funet, 2013,31(5):427-433.
  • 10Motzer R J, Bukowski R M. Targeted therapy for metastatic renal cell carcinoma[J]. J Clin Oncol, 2006,24(35):5601-5608.

二级参考文献58

  • 1康春生,浦佩玉,李捷,王广秀.反义及显性负调节AKT2 RNA对脑胶质瘤细胞增殖抑制作用的体外研究[J].癌症,2004,23(11):1267-1272. 被引量:5
  • 2王宏梅,陈龙华,郑小康,李启生,伍新尧,夏云飞.抑制ATM/PI3K功能区表达对鼻咽癌细胞CNE1辐射增敏的研究[J].癌症,2006,25(9):1097-1101. 被引量:9
  • 3Atkins M B, Hidalgo M, Stadler W M, et al. Randomized phase Ⅱ study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma [J]. J Clin Oncol, 2004, 22(5) :909-918.
  • 4Christian T, James R, Zoran F, et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer : implications for therapy [ J ]. Proc Natl Acad Sci USA, 2006,103 (6) : 1888-1893.
  • 5Adachi S, Leoni L M, Carson D A, et al. Apoptosis induced by molecular targeting therapy in hematological malignancies [J]. Acta Haematol, 2004,111(1-2) : 107-123.
  • 6Campiglio M, Olgiati C, Normanno N, et al. Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ( 'Iressa' ) is independent of EGFR expression level [J]. J Cell Physiol, 2004,198(2): 259-268.
  • 7Zhang M, Fang X, Liu H, et al. Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chIoro-2-methylellipticinium acetate (CMEP) [J]. Biochem Pharmacol, 2007,73( 1 ) : 15-24.
  • 8Douglas A L, Faina B, Cindy J Y, et al. Frequent mutation of the P1K3CA gene in ovarian and breast cancer [J]. Clin Cancer Res, 2005,11 (8):2875- 2878.
  • 9Knobbe C B, Kieslich A T, Reifenberger G. Genetic alteration and expression of the phosphoinositol-3- kinase/Akt pathway genes P1K3CA and PIKE in human glioblastomas [J]. Neuropathol Appl Neurobiol, 2005, 31 (5) :486-490.
  • 10Oda K, Stokoe D, Taketani Y, et al. High frequency of coexistent mutations of P1K3CA and PTEN genes in endometrial carcinoma [ R ]. Cancer Res, 2005,65(23) : 10669-10673.

共引文献118

同被引文献18

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部